Pediatric Hydroxyurea Phase III Clinical Trial (BABY HUG) Follow-up Observational Study II Protocol

CompletedOBSERVATIONAL
Enrollment

150

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

December 31, 2016

Study Completion Date

December 31, 2016

Conditions
Sickle Cell Anemia
Interventions
DRUG

Hydroxyurea

Parents and child's doctor may plan to use or not to use hydroxyurea.

Trial Locations (14)

11203

Downstate Medical Center, Brooklyn

20010

Children's National Medical Center Center for Cancer and Blood Disorders, Washington D.C.

20060

Howard University College of Medicine, Washington D.C.

21205

Johns Hopkins University School of Medicine, Baltimore

21215

Sinai Hospital of Baltimore Alfred I Coplan Pediatric Hematology Oncology Outpatient Center, Baltimore

27710

Duke University Medical Center, Durham

29425

Medical University of South Carolina, Charleston

30342

Emory University School of Medicine, Atlanta

33136

University of Miami School of Medicine, Miami

35233

University of Alabama at Birmingham, Birmingham

38105

St. Jude Children's Research Hospital, Memphis

39216

University of Mississippi Medical Center, Jackson

48201

Children's Hospital of Michigan/Wayne State University, Detroit

75390

University of Texas Southwestern Medical Center at Dallas, Dallas

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

lead

National Heart, Lung, and Blood Institute (NHLBI)

NIH

NCT01783990 - Pediatric Hydroxyurea Phase III Clinical Trial (BABY HUG) Follow-up Observational Study II Protocol | Biotech Hunter | Biotech Hunter